SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Ocera Therapeutics, Inc.: Liver Failure Group Present Two Studies on a Novel Treatment Option for Complications of Hyperammonemia in Liver Failure at the 60th Annual AASLD Meeting